Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-PD-1 Antibody (2U287)

😃Good
Catalog No. TMAH-00864
Alias SLEB2, PDCD1, PD-1, PD1, CD279

Anti-PD-1 Antibody (2U287) is an antibody targeting PD-1. Anti-PD-1 Antibody (2U287) can be used in ELISA.

Anti-PD-1 Antibody (2U287)

Anti-PD-1 Antibody (2U287)

😃Good
Catalog No. TMAH-00864Alias SLEB2, PDCD1, PD-1, PD1, CD279
Anti-PD-1 Antibody (2U287) is an antibody targeting PD-1. Anti-PD-1 Antibody (2U287) can be used in ELISA.
Pack SizePriceAvailabilityQuantity
50 μL$209 7-10 days
100 μL$348 7-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Antibody Type: Recombinant Monoclonal

Application: ELISA

Reactivity: Human
AliasSLEB2, PDCD1, PD-1, PD1, CD279
Ig Type
Human IgG4
Clone
2U287
Reactivity
Human
Verified Activity
The Binding Activity of PD-1 with anti-PD-1 antibody
Activity: Measured by its binding ability in a functional ELISA. Immobilized Human PD-1 at 2 μg/mL can bind Anti-PD-1 recombinant antibody, the EC50 is 1.960-3.961 ng/mL.
Application
ELISA
Antibody Type
Monoclonal
Subcellular LocalizationCell membrane; Single-pass type I membrane protein.
ConstructionRecombinant Antibody
PurificationAffinity-chromatography
AppearanceLiquid
FormulationPreservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4.
Research BackgroundInhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2. Following T-cell receptor (TCR) engagement, PDCD1 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation. Suppresses T-cell activation through the recruitment of PTPN11/SHP-2: following ligand-binding, PDCD1 is phosphorylated within the ITSM motif, leading to the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with CD274/PDCD1L1 inhibits cytotoxic T lymphocytes (CTLs) effector function. The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Human PD-1 Protein
Antigen Species
Human
Gene ID
5133
Uniprot ID
Biology Area
Immunology
Chemical Properties
Stability & Storage
Stability & StorageStore at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Anti-PD-1 Antibody (2U287) | purchase Anti-PD-1 Antibody (2U287) | Anti-PD-1 Antibody (2U287) cost | order Anti-PD-1 Antibody (2U287)